BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

553 related articles for article (PubMed ID: 31202781)

  • 1. Oridonin synergistically enhances the anti-tumor efficacy of doxorubicin against aggressive breast cancer via pro-apoptotic and anti-angiogenic effects.
    Li J; Wu Y; Wang D; Zou L; Fu C; Zhang J; Leung GP
    Pharmacol Res; 2019 Aug; 146():104313. PubMed ID: 31202781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic breast cancer suppression efficacy of doxorubicin by combination with glycyrrhetinic acid as an angiogenesis inhibitor.
    Shi J; Li J; Li J; Li R; Wu X; Gao F; Zou L; Mak WWS; Fu C; Zhang J; Leung GP
    Phytomedicine; 2021 Jan; 81():153408. PubMed ID: 33234363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oridonin induces apoptosis, inhibits migration and invasion on highly-metastatic human breast cancer cells.
    Wang S; Zhong Z; Wan J; Tan W; Wu G; Chen M; Wang Y
    Am J Chin Med; 2013; 41(1):177-96. PubMed ID: 23336515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eriocalyxin B, a natural diterpenoid, inhibited VEGF-induced angiogenesis and diminished angiogenesis-dependent breast tumor growth by suppressing VEGFR-2 signaling.
    Zhou X; Yue GG; Liu M; Zuo Z; Lee JK; Li M; Tsui SK; Fung KP; Sun H; Pu J; Lau CB
    Oncotarget; 2016 Dec; 7(50):82820-82835. PubMed ID: 27756875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnoflorine improves sensitivity to doxorubicin (DOX) of breast cancer cells via inducing apoptosis and autophagy through AKT/mTOR and p38 signaling pathways.
    Wei T; Xiaojun X; Peilong C
    Biomed Pharmacother; 2020 Jan; 121():109139. PubMed ID: 31707337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oridonin inhibits tumor growth and metastasis through anti-angiogenesis by blocking the Notch signaling.
    Dong Y; Zhang T; Li J; Deng H; Song Y; Zhai D; Peng Y; Lu X; Liu M; Zhao Y; Yi Z
    PLoS One; 2014; 9(12):e113830. PubMed ID: 25485753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiangiogenic effects of oridonin.
    Tian L; Xie K; Sheng D; Wan X; Zhu G
    BMC Complement Altern Med; 2017 Apr; 17(1):192. PubMed ID: 28376864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multifunctional hybrid nanoconstructs facilitate intracellular localization of doxorubicin and genistein to enhance apoptotic and anti-angiogenic efficacy in breast adenocarcinoma.
    Shukla RP; Dewangan J; Urandur S; Banala VT; Diwedi M; Sharma S; Agrawal S; Rath SK; Trivedi R; Mishra PR
    Biomater Sci; 2020 Mar; 8(5):1298-1315. PubMed ID: 31903460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of Carbonyl Reductase 1 Safely Improves the Efficacy of Doxorubicin in Breast Cancer Treatment.
    Jo A; Choi TG; Jo YH; Jyothi KR; Nguyen MN; Kim JH; Lim S; Shahid M; Akter S; Lee S; Lee KH; Kim W; Cho H; Lee J; Shokat KM; Yoon KS; Kang I; Ha J; Kim SS
    Antioxid Redox Signal; 2017 Jan; 26(2):70-83. PubMed ID: 27357096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oridonin enhances antitumor effects of doxorubicin in human osteosarcoma cells.
    Kazantseva L; Becerra J; Santos-Ruiz L
    Pharmacol Rep; 2022 Feb; 74(1):248-256. PubMed ID: 34427908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. pH-sensitive polymeric nanoparticles for co-delivery of doxorubicin and curcumin to treat cancer via enhanced pro-apoptotic and anti-angiogenic activities.
    Zhang J; Li J; Shi Z; Yang Y; Xie X; Lee SM; Wang Y; Leong KW; Chen M
    Acta Biomater; 2017 Aug; 58():349-364. PubMed ID: 28455219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oridonin exhibits anti-angiogenic activity in human umbilical vein endothelial cells by inhibiting VEGF-induced VEGFR-2 signaling pathway.
    Jiang JH; Pi J; Cai JY
    Pathol Res Pract; 2020 Aug; 216(8):153031. PubMed ID: 32703495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Novel Potent Anticancer Compound Optimized from a Natural Oridonin Scaffold Induces Apoptosis and Cell Cycle Arrest through the Mitochondrial Pathway.
    Xu S; Yao H; Luo S; Zhang YK; Yang DH; Li D; Wang G; Hu M; Qiu Y; Wu X; Yao H; Xie W; Chen ZS; Xu J
    J Med Chem; 2017 Feb; 60(4):1449-1468. PubMed ID: 28165738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resveratrol enhances chemosensitivity of doxorubicin in multidrug-resistant human breast cancer cells via increased cellular influx of doxorubicin.
    Kim TH; Shin YJ; Won AJ; Lee BM; Choi WS; Jung JH; Chung HY; Kim HS
    Biochim Biophys Acta; 2014 Jan; 1840(1):615-25. PubMed ID: 24161697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-angiogenic activity and mechanism of kaurane diterpenoids from Wedelia chinensis.
    Huang W; Liang Y; Wang J; Li G; Wang G; Li Y; Chung HY
    Phytomedicine; 2016 Mar; 23(3):283-92. PubMed ID: 26969382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Dahuang zhechong pill on doxorubicin-resistant SMMC-7721 xenografts in mice.
    Wu L; Cao KX; Ni ZH; Li WD; Chen ZP; Cheng HB; Liu X
    J Ethnopharmacol; 2018 Aug; 222():71-78. PubMed ID: 29609009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Poly-l-Lysine inhibits VEGF and c-Myc mediated tumor-angiogenesis and induces apoptosis in 2D and 3D tumor microenvironment of both MDA-MB-231 and B16F10 induced mice model.
    Debnath S; Mukherjee A; Saha D; Dash J; Chatterjee TK
    Int J Biol Macromol; 2021 Jul; 183():528-548. PubMed ID: 33892042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gold nanoparticle-conjugated quercetin inhibits epithelial-mesenchymal transition, angiogenesis and invasiveness via EGFR/VEGFR-2-mediated pathway in breast cancer.
    Balakrishnan S; Bhat FA; Raja Singh P; Mukherjee S; Elumalai P; Das S; Patra CR; Arunakaran J
    Cell Prolif; 2016 Dec; 49(6):678-697. PubMed ID: 27641938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oridonin promotes RSL3-induced ferroptosis in breast cancer cells by regulating the oxidative stress signaling pathway JNK/Nrf2/HO-1.
    Ye S; Hu X; Sun S; Su B; Cai J; Jiang J
    Eur J Pharmacol; 2024 Jul; 974():176620. PubMed ID: 38685305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oleanolic Acid Inhibits Colorectal Cancer Angiogenesis by Blocking the VEGFR2 Signaling Pathway.
    Niu G; Sun L; Pei Y; Wang D
    Anticancer Agents Med Chem; 2018; 18(4):583-590. PubMed ID: 29065844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.